AkzoNobel

Sell on this relatively good news

23/04/24 -"Akzo’s Q1 delivered a strong set of consensus-beating figures (sales: +1.9%; adjusted EBITDA: +4.3%; net profit: +23.4%). After all the past trouble with the guidance and the price increases in the ..."

PDF page sample
Pages
61
Language
English
Published on
23/04/24
Download
You may also be interested by these reports :
19/09/24
No big news, but reiteration of ambitious targets with clear road map is positive for the stock in our view
13/09/24
Deep Cyclicals slip on. AlphaValue defines them as the sum of Oils, Metals & Mining, Chemicals, Paper & Packaging. This is 72 stocks under ...
09/09/24
Having integrated the latest figures, we deducted our forecast, especially on the profitability side. We see Clean Air burdened by the lower car ...
03/09/24
Portfolio rotation has been a key profitability driver and a crucial aspect of Arkema’s (Buy; France) equity narrative. Its 2028 targets appear to be ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO